• Skip to main content
  • Skip to footer
  • Home
  • About
    • MyPE Copyright Terms
    • Authors
    • Deals
  • Info
    • Accommodation
    • Classified Adverts
    • Directory
    • Essential PE Numbers
    • Flight Schedules
    • Forex Converter
    • PE’s Online Radio Stations
      • Algoa FM
      • Bay FM
      • iFM
      • Kingfisher FM
      • MannMade Radio
      • Madibaz Radio
      • Umhlobo Wenene
    • Podcasts
    • Shipping
    • Street Map
    • Tides
    • Ward Details
    • Ward News
    • Weather
  • Contact
    • Advertising on MyPE
  • Submit
    • Blogger
    • 5 Quick PE Questions
    • Entertainment
    • Events
      • Add your Port Elizabeth event
    • Letter to the Editor
    • Lost and Found
    • Movers and Shakers
    • News Article
    • PE Videos
    • Photographs
    • Recipes
    • Traffic Hooligan
    • Say NO
  • Dam Levels
  • Advertorial
  • Business
  • NMBRA
  • NMB Rates
MyPE

MyPE

Community Business Directory, Event Listings, News and Views from Gqeberha, Nelson Mandela Bay

Evaluation of Sinovac Biotech vaccine at a “very advanced stage”

22 June 2021 By Alan Straton

The evaluation of the CoronaVac COVID-19 vaccine, produced by Chinese pharmaceutical company Sinovac Biotech, is at “very advanced stages”.

This is according to the South African Health Products Regulatory Authority (SAHPRA), as the country races against the clock to get more lifesaving COVID-19 jabs.

“Furthermore, reports recently made available by the World Health Organisation (WHO) that articulate the basis for the Emergency Use Listing is being considered,” said SAHRPA on Monday.

Last month, the WHO approved China’s Sinovac COVID-19 vaccine for emergency use and recommended the use on people with comorbidities such as obesity, cardiovascular disease, and respiratory disease.

According to the WHO, a trial in Brazil showed that two doses, administered at an interval of 14 days, had an efficacy of 51% against symptomatic SARS-CoV-2 infection, 100% against severe COVID-19, and 100% against hospitalisation starting 14 days after receiving the second dose.

Sputnik V

Meanwhile, Russia’s Sputnik V application is a rolling review, “thus as data becomes available to the applicant it is submitted to SAHPRA”.

SAHPRA is an independent health products regulatory authority focusing on quality, safety, and efficacy.

“These core elements of its mandate also apply to COVID-19 vaccines as well.”

The drug watchdog said clinical trial data for safety and efficacy from phase one to three should be provided together with manufacturing information of the product quality.

“The assessment is then conducted considering all information provided.”

However, to respond to the pandemic, SAHPRA introduced another mechanism to facilitate the review of COVID-19 applications, which is the rolling review process.

“The rolling review is a mechanism that facilitates the submission of data as it becomes available. Whilst reviews can commence earlier with a rolling submission, it is important to note that some very important efficacy, quality, and safety information is sometimes outstanding and would require review for consideration of such products for public use.”

Therefore, SAHPRA said pharmaceutical companies could submit applications indicating a plan of when they will be submitting their data, that is, outline when the next rolling submission sequence is available for review.

“When an applicant submits their respective dossiers, SAHPRA works closely with the applicant in evaluating the data.”

The team of technical, subject matter experts within SAHPRA and external members, appointed by the Chief Executive Officer (CEO), evaluate these applications.

“SAHPRA also works closely with other regulators across the world as well as with the WHO in assessing the quality, safety and efficacy of health products, and in this case, COVID-19 vaccines.”

Meanwhile, the watchdog said it cannot approve any product if an application has not been submitted to the authority.

Sinopharm and Moderna vaccines

“Thus, there is no SAHPRA decision on Sinopharm and Moderna vaccines, which have a WHO Emergency Use Listing, as there have not been any applications for these vaccines in South Africa.”

So far, SAHPRA has approved the Pfizer and the Johnson & Johnson vaccines.

Meanwhile, the regulator said it has to take into account the prevalence of variants of concern such as the Beta variant in South Africa.

“This requires that SAHPRA ensures efficacy against such variants and hence information on studies supporting efficacy would be expected to be provided by the applicant.”

SAHPRA’s CEO, Dr Boitumelo Semete-Makokotlela, reiterated the commitment to prioritise all COVID-19- related health products, including vaccines, as the world and South Africa grapple with ending the scourge of a pandemic of “mammoth” proportions.

“SAHPRA will not be pressured to allow the public access to any product that has not met the necessary regulatory requirements,” she added. – SAnews.gov.za

Go On – Share the Gqeberha Love!

Gqeberha’s Latest News and Events can be accessed on MyGqeberha.com.

The following two tabs change content below.
  • Bio
  • Latest Posts
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Alan Straton

Chief Cook, Bottle Washer and Broom Mechanic at MyPE
Passionate about Port Elizabeth and definitely NOT packing for Perth. Alan's ethos is epitomised in the words of Nelson Mandela; "I have fought against white domination and I have fought against black domination. I have cherished the idea of a democratic and free society. If need be, it is an ideal for which I am prepared to die." See more articles by Alan.
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Latest posts by Alan Straton (see all)

  • Can Too Much Screen Time Increase Childhood Obesity? - 20 November 2026
  • Chilla Brings Mango, Watermelon and Blueberry Bubble Tea to South Africa - 20 November 2026
  • Short Festive Runs Still Need Readable Batch Codes, Says Pinetown Coding Ink Supplier - 20 November 2026
  • Africa Exhibitions Brings Freestanding Heritage Shows to Libraries and Museums Where Walls Stay Untouched - 20 November 2026
  • Pretoria East Renal Clinic Publishes a What-to-Bring List for Specialist and Dialysis Visits - 20 November 2026

Filed Under: Community Tagged With: MyGqeberha

Footer

RSS Straton Electrical

  • Open Cycle Gas Turbine Usage
  • Flattening the curve – What Every Solar Installer Needs to Know
  • Why you shouldn’t leave a charger plugged in when not in use
  • How do I check if an Electrician is properly registered in South Africa?
  • Easy Electrical Troubleshooting for Humans
  • Water – If You Cannot Measure It Then You Cannot Manage It
  • Tips To Survive Loadshedding
  • Eskom’s Top 50 Electricity Saving Tips

RSS MyPE Business News

  • NMBBC On Budget 2025
  • Leading Business Minds Set to Headline Chambers Annual General Meeting
  • Bay of Opportunity Portal
  • Bay of Opportunity Ambassadors Programme to Promote the Bay and Attract Investment
  • 6 Decades of Trucking
  • Thermal Camera Installed at Redhouse Substation
  • Finalist in the 2025 South African Car of the Year
  • Joining hands to create a lasting impact to St Albans Primary School

RSS MyPR Press Releases

How you may use MyPE content © 2026 MyPE · Gqeberha, South Africa | Privacy Policy | MyPE Ads and Media Kit